WG
ECYT

Winton Group’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Winton Group’s Portfolio ECYT Stock Details ECYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-12,494
Closed -$222K – 1113
2018
Q3 		$222K Buy
+12,494
New +$214K ﹤0.01% 935

Other funds holding ECYT

OTC
Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return
CA
Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return

Winton Group's ECYT Position: Q4 2018 in Review

Winton Group sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 12,494 shares — an estimated $222K sold.

Winton Group first reported a position in ECYT in Q3 2018 and held it in 1 quarter. The position peaked at $222K in Q3 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

  • Winton Group reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • Winton Group sold 12,494 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $222K.
  • Winton Group first reported a position in Endocyte, Inc. Common Stock in Q3 2018 and held it in 1 quarter.
  • Winton Group's Endocyte, Inc. Common Stock position peaked at $222K in Q3 2018.
  • 2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on Winton Group's 13F filing for Q4 2018, filed 5 Feb 2019.